{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:44:22Z","timestamp":1789825462334,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and Hypothesis<\/jats:title>\n                    <jats:p>The vaginal and urinary microbiomes are closely linked, yet the role of this relationship in recurrent and chronic urinary tract infections (UTIs) remains uncertain. Research into genitourinary ecology and UTI has largely focused on acute infections and reproductive age groups, leaving a gap in understanding the role of the microbiome in recurrent and chronic cases. This review is aimed at presenting that disruptions within vaginal microbiota contribute to UTI chronicity in menopausal women, highlighting the potential for microbiome-targeted interventions in this high-risk group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature review was conducted, with search terms including cystitis, urogenital, antibiotic, infection, and bladder, vaginal microbiome, vaginal ecology, topical oestrogen, atrophy, genitourinary syndrome of menopause, vulvo-vaginal atrophy (VVA), bacterial vaginosis and lactobacillus. Relevant articles were screened, critiqued, and synthesised based on key themes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp. appears to be the key component of a healthy vaginal microbiome. Decreased vaginal\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      abundance, seen with vaginal dysbioses and the menopause, correlates with an increased presence of urinary pathogens, increasing susceptibility to UTI. This review demonstrates that interventions to optimise vaginal ecology could reduce UTI burden. These approaches offer non-antibiotic treatment strategies, lowering antimicrobial resistance risk. However, studies frequently exclude those with chronic and recurrent infections, underscoring the necessity for more research targeting this group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review highlights the link between disrupted vaginal ecology and recurrent and chronic UTI, and the need for expanded research into microbiome-targeted treatments. A paucity of studies researching recurrent and chronic UTI cohorts limits the evidence base for clinical generalisation, meaning that more focussed studies are needed to improve understanding and clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00192-025-06434-1","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:17:20Z","timestamp":1765189040000},"page":"1869-1879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Vaginal Microbiome and Recurrent and Chronic Urinary Tract Infection"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9307-9901","authenticated-orcid":false,"given":"Katie L.","family":"Dalby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Horsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajvinder","family":"Khasriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"1","key":"6434_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mucimm.2022.12.003","volume":"16","author":"CCY Chieng","year":"2023","unstructured":"Chieng CCY, Kong Q, Liou NSY, Khasriya R, Horsley H. The clinical implications of bacterial pathogenesis and mucosal immunity in chronic urinary tract infection. Mucosal Immunol. 2023;16(1):61\u201371.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"6434_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","volume":"18","author":"F Wagenlehner","year":"2018","unstructured":"Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):107\u201317.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"6434_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11934-022-01132-7","volume":"24","author":"A Nemirovsky","year":"2023","unstructured":"Nemirovsky A, Villela NA, Yuan JC, Patil R, Malik RD. Vaginal hormone therapy for conditions of the lower urinary tract. Curr Urol Rep. 2023;24(2):41\u201350.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"6434_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1086\/313596","volume":"30","author":"R Raz","year":"2000","unstructured":"Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30(1):152\u20136.","journal-title":"Clin Infect Dis"},{"key":"6434_CR5","unstructured":"EAU Guidelines on urological infections\u2014uroweb. Accessed 10 January 2025. Available from: https:\/\/uroweb.org\/guidelines\/urological-infections\/chapter\/the-guideline"},{"issue":"7","key":"6434_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00192-018-3569-7","volume":"29","author":"S Swamy","year":"2018","unstructured":"Swamy S, Barcella W, De Iorio M, Gill K, Khasriya R, Kupelian AS, et al. Recalcitrant chronic bladder pain and recurrent cystitis but negative urinalysis: what should we do? Int Urogynecol J. 2018;29(7):1035\u201343.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"6434_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4111\/icu.20220357","volume":"64","author":"HW Choi","year":"2023","unstructured":"Choi HW, Lee KW, Kim YH. Microbiome in urological diseases: Axis crosstalk and bladder disorders. Investig Clin Urol. 2023;64(2):126\u201339.","journal-title":"Investig Clin Urol"},{"issue":"33","key":"6434_CR8","doi-asserted-by":"publisher","first-page":"e2117904119","DOI":"10.1073\/pnas.2117904119","volume":"119","author":"CH Song","year":"2022","unstructured":"Song CH, Kim YH, Naskar M, Hayes BW, Abraham MA, Noh JH, et al. Lactobacillus crispatus limits bladder uropathogenic E. coli infection by triggering a host type I interferon response. Proc Natl Acad Sci USA. 2022;119(33):e2117904119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6434_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","volume":"66","author":"B Ma","year":"2012","unstructured":"Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371\u201389.","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"6434_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11908-022-00794-1","volume":"25","author":"OT Van Gerwen","year":"2023","unstructured":"Van Gerwen OT, Smith SE, Muzny CA. Bacterial vaginosis in postmenopausal women. Curr Infect Dis Rep. 2023;25(1):7\u201315.","journal-title":"Curr Infect Dis Rep"},{"issue":"12","key":"6434_CR11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00192-018-3767-3","volume":"29","author":"KJ Thomas-White","year":"2018","unstructured":"Thomas-White KJ, Gao X, Lin H, Fok CS, Ghanayem K, Mueller ER, et al. Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients. Int Urogynecol J. 2018;29(12):1797\u2013805.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"6434_CR12","doi-asserted-by":"publisher","first-page":"154.e1","DOI":"10.1016\/j.ajog.2019.08.011","volume":"222","author":"YM Komesu","year":"2020","unstructured":"Komesu YM, Dinwiddie DL, Richter HE, Lukacz ES, Sung VW, Siddiqui NY, et al. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1\u201310.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"6434_CR13","doi-asserted-by":"publisher","first-page":"e0283215","DOI":"10.1371\/journal.pone.0283215","volume":"18","author":"Y Kim","year":"2023","unstructured":"Kim Y, Bergerat-Thompson A, Mitchell C. Vaginal and urinary evaluation of lactobacilli quantification by qPCR: identifying factors that influence urinary detection and the quantity of Lactobacillus. PLoS ONE. 2023;18(4):e0283215.","journal-title":"PLoS ONE"},{"issue":"1","key":"6434_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/diagnostics11010007","volume":"11","author":"T Me\u0161trovi\u0107","year":"2021","unstructured":"Me\u0161trovi\u0107 T, Matija\u0161i\u0107 M, Peri\u0107 M, \u010cip\u010di\u0107Paljetak H, Bare\u0161i\u0107 A, Verbanac D. The role of gut, vaginal, and urinary microbiome in urinary tract infections: from bench to bedside. Diagnostics. 2021;11(1):7.","journal-title":"Diagnostics"},{"issue":"5","key":"6434_CR15","doi-asserted-by":"publisher","first-page":"112474","DOI":"10.1016\/j.celrep.2023.112474","volume":"42","author":"AR Berard","year":"2023","unstructured":"Berard AR, Brubaker DK, Birse K, Lamont A, Mackelprang RD, No\u00ebl-Romas L, et al. Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling. Cell Rep. 2023;42(5):112474.","journal-title":"Cell Rep"},{"issue":"9","key":"6434_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/humrep\/16.9.1809","volume":"16","author":"ER Boskey","year":"2001","unstructured":"Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: high D\/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod. 2001;16(9):1809\u201313.","journal-title":"Hum Reprod"},{"issue":"2","key":"6434_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/jcm.27.2.251-256.1989","volume":"27","author":"DA Eschenbach","year":"1989","unstructured":"Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989;27(2):251\u20136.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"6434_CR18","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/cid\/cir183","volume":"52","author":"AE Stapleton","year":"2011","unstructured":"Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6434_CR19","first-page":"035387","volume":"2007","author":"CA Czaja","year":"2007","unstructured":"Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol. 2007;2007(1):035387.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"7","key":"6434_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1258\/09564620260079581","volume":"13","author":"D Taylor-Robinson","year":"2002","unstructured":"Taylor-Robinson D, McCaffrey M, Pitkin J, Lamont RF. Bacterial vaginosis in climacteric and menopausal women. Int J STD AIDS. 2002;13(7):449\u201352.","journal-title":"Int J STD AIDS"},{"key":"6434_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.590877\/full","volume":"11","author":"L Geng","year":"2020","unstructured":"Geng L, Huang W, Jiang S, Zheng Y, Zhou Y, Zhou Y, et al. Effect of menopausal hormone therapy on the vaginal microbiota and genitourinary syndrome of menopause in Chinese menopausal women. Front Microbiol. 2020;11:590877. https:\/\/doi.org\/10.3389\/fmicb.2020.590877\/full.","journal-title":"Front Microbiol"},{"issue":"5","key":"6434_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/GME.0000000000001037","volume":"25","author":"CM Mitchell","year":"2018","unstructured":"Mitchell CM, Srinivasan S, Plantinga A, Wu MC, Reed SD, Guthrie KA, et al. Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem. Menopause. 2018;25(5):500\u20137.","journal-title":"Menopause"},{"issue":"3","key":"6434_CR23","doi-asserted-by":"publisher","first-page":"e225032","DOI":"10.1001\/jamanetworkopen.2022.5032","volume":"5","author":"S Srinivasan","year":"2022","unstructured":"Srinivasan S, Hua X, Wu MC, Proll S, Valint DJ, Reed SD, et al. Impact of topical interventions on the vaginal microbiota and metabolome in postmenopausal women: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2022;5(3):e225032.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"6434_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/02813439209014051","volume":"10","author":"AL Kirkengen","year":"1992","unstructured":"Kirkengen AL, Andersen P, Gjers\u00f8e E, Johannessen GR, Johnsen N, Bodd E. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scand J Prim Health Care. 1992;10(2):139\u201342.","journal-title":"Scand J Prim Health Care"},{"issue":"5","key":"6434_CR25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","volume":"180","author":"BC Eriksen","year":"1999","unstructured":"Eriksen BC. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180(5):1072\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"6434_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM199309093291102","volume":"329","author":"R Raz","year":"1993","unstructured":"Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):743\u201356.","journal-title":"N Engl J Med"},{"issue":"9","key":"6434_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","volume":"172","author":"MAJ Beerepoot","year":"2012","unstructured":"Beerepoot MAJ, ter Riet G, Nys S, van der Wal WM, de Borgie CAJM, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704\u201312.","journal-title":"Arch Intern Med"},{"key":"6434_CR28","doi-asserted-by":"publisher","first-page":"1187479","DOI":"10.3389\/fmicb.2023.1187479","volume":"14","author":"T Sekito","year":"2023","unstructured":"Sekito T, Wada K, Ishii A, Iwata T, Matsubara T, Tomida S, et al. Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository. Front Microbiol. 2023;14:1187479.","journal-title":"Front Microbiol"},{"issue":"6","key":"6434_CR29","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/SPV.0000000000001170","volume":"28","author":"JN Lillemon","year":"2022","unstructured":"Lillemon JN, Karstens L, Nardos R, Garg B, Boniface ER, Gregory WT. The impact of local estrogen on the urogenital microbiome in genitourinary syndrome of menopause: a randomized-controlled trial. Female Pelvic Med Reconstr Surg. 2022;28(6):e157.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"2","key":"6434_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1086\/515635","volume":"178","author":"K Gupta","year":"1998","unstructured":"Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis. 1998;178(2):446\u201350.","journal-title":"J Infect Dis"},{"key":"6434_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jgar.2019.02.021","volume":"19","author":"A Ray Mohapatra","year":"2019","unstructured":"Ray Mohapatra A, Jeevaratnam K. Inhibiting bacterial colonization on catheters: antibacterial and antibiofilm activities of bacteriocins from Lactobacillus plantarum SJ33. J Glob Antimicrob Resist. 2019;19:85\u201392.","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"6434_CR32","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-020-16627-5","volume":"11","author":"JR Brannon","year":"2020","unstructured":"Brannon JR, Dunigan TL, Beebout CJ, Ross T, Wiebe MA, Reynolds WS, et al. Invasion of vaginal epithelial cells by uropathogenic Escherichia coli. Nat Commun. 2020;11(1):2803.","journal-title":"Nat Commun"},{"issue":"12","key":"6434_CR33","doi-asserted-by":"publisher","first-page":"e0270242","DOI":"10.1371\/journal.pone.0270242","volume":"17","author":"R Yoshikata","year":"2022","unstructured":"Yoshikata R, Yamaguchi M, Mase Y, Tatsuyuki A, Myint KZY, Ohta H. Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: a pilot randomized controlled trial. PLoS ONE. 2022;17(12):e0270242.","journal-title":"PLoS ONE"},{"key":"6434_CR34","doi-asserted-by":"publisher","first-page":"1402389","DOI":"10.3389\/fcimb.2024.1402389","volume":"14","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Shu H, Pan H, Zhang Y, Fan L, Huang Y, et al. Associations of vaginal microbiota with the onset, severity, and type of symptoms of genitourinary syndrome of menopause in women. Front Cell Infect Microbiol. 2024;14:1402389.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"6434_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/MAJ.0b013e31823ea228","volume":"343","author":"DH Martin","year":"2012","unstructured":"Martin DH. The microbiota of the vagina and its influence on women\u2019s health and disease. Am J Med Sci. 2012;343(1):2\u20139.","journal-title":"Am J Med Sci"},{"key":"6434_CR36","doi-asserted-by":"publisher","first-page":"686167","DOI":"10.3389\/fcimb.2021.686167","volume":"11","author":"RS Auriemma","year":"2021","unstructured":"Auriemma RS, Scairati R, del Vecchio G, Liccardi A, Verde N, Pirchio R, et al. The vaginal microbiome: a long urogenital colonization throughout woman life. Front Cell Infect Microbiol. 2021;11:686167.","journal-title":"Front Cell Infect Microbiol"},{"key":"6434_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005131.pub2\/full","author":"C Perrotta","year":"2008","unstructured":"Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008. https:\/\/doi.org\/10.1002\/14651858.CD005131.pub2\/full.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"6434_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1067\/mob.2002.123987","volume":"186","author":"L Hillebrand","year":"2002","unstructured":"Hillebrand L, Harmanli OH, Whiteman V, Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis. Am J Obstet Gynecol. 2002May 1;186(5):916\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6434_CR39","doi-asserted-by":"publisher","first-page":"e1009876","DOI":"10.1371\/journal.pcbi.1009876","volume":"18","author":"NA Bokulich","year":"2022","unstructured":"Bokulich NA, \u0141aniewski P, Adamov A, Chase DM, Caporaso JG, Herbst-Kralovetz MM. Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment. PLoS Comput Biol. 2022;18(2):e1009876.","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"6434_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/GME.0b013e3182a4690b","volume":"21","author":"RM Brotman","year":"2014","unstructured":"Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21(5):450\u20138.","journal-title":"Menopause"},{"issue":"6","key":"6434_CR41","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/GME.0000000000001515","volume":"27","author":"KS Mark","year":"2020","unstructured":"Mark KS, Tenorio B, Stennett CA, Ghanem KG, Brotman RM. Bacterial vaginosis diagnosis and treatment in postmenopausal women: a survey of clinician practices. Menopause. 2020;27(6):679\u201383.","journal-title":"Menopause"},{"issue":"9","key":"6434_CR42","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1001\/archinte.1989.00390090014003","volume":"149","author":"TM Hooton","year":"1989","unstructured":"Hooton TM, Fihn SD, Johnson C, Roberts PL, Stamm WE. Association between bacterial vaginosis and acute cystitis in women using diaphragms. Arch Intern Med. 1989;149(9):1932\u20136.","journal-title":"Arch Intern Med"},{"issue":"5","key":"6434_CR43","first-page":"710","volume":"95","author":"OH Harmanli","year":"2000","unstructured":"Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Gaughan JP. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol. 2000;95(5):710.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"6434_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/13697137.2023.2223923","volume":"26","author":"G Stabile","year":"2023","unstructured":"Stabile G, Topouzova GA, De Seta F. The role of microbiota in the management of genitourinary syndrome of menopause. Climacteric. 2023;26(4):353\u201360.","journal-title":"Climacteric"},{"key":"6434_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.maturitas.2017.02.004","volume":"99","author":"M Caretto","year":"2017","unstructured":"Caretto M, Giannini A, Russo E, Simoncini T. Preventing urinary tract infections after menopause without antibiotics. Maturitas. 2017;99:43\u20136.","journal-title":"Maturitas"},{"issue":"2","key":"6434_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcgg.2010.10.008","volume":"1","author":"KJ Leckie","year":"2010","unstructured":"Leckie KJ. What is the evidence for the role of oestrogen in the prevention of recurrent urinary tract infections in postmenopausal women? An evidence-based review. J Clin Gerontol Geriatr. 2010;1(2):31\u20135.","journal-title":"J Clin Gerontol Geriatr"},{"issue":"5","key":"6434_CR47","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/nau.21106","volume":"30","author":"D Robinson","year":"2011","unstructured":"Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011;30(5):754\u20137.","journal-title":"Neurourol Urodyn"},{"key":"6434_CR48","unstructured":"Overview | Urinary tract infection (recurrent): antimicrobial prescribing | Guidance | NICE. NICE;2018. Accessed 5 December 2024. Available from: https:\/\/www.nice.org.uk\/guidance\/ng112."},{"key":"6434_CR49","doi-asserted-by":"publisher","first-page":"779398","DOI":"10.3389\/frph.2021.779398","volume":"3","author":"ACA Sarmento","year":"2021","unstructured":"Sarmento ACA, Costa APF, Vieira-Baptista P, Giraldo PC, Eleut\u00e9rio J, Gon\u00e7alves AK. Genitourinary syndrome of menopause: epidemiology, physiopathology, clinical manifestation and diagnostic. Front Reprod Health. 2021;3:779398.","journal-title":"Front Reprod Health"},{"issue":"11","key":"6434_CR50","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/diagnostics11111996","volume":"11","author":"YP Lin","year":"2021","unstructured":"Lin YP, Chen WC, Cheng CM, Shen CJ. Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics. 2021;11(11):1996.","journal-title":"Diagnostics"},{"issue":"7","key":"6434_CR51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/GME.0000000000001081","volume":"25","author":"KM Tucker","year":"2018","unstructured":"Tucker KM, Godha K, Mirkin S, Archer DF. Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women. Menopause. 2018;25(7):762\u20136.","journal-title":"Menopause"},{"issue":"8","key":"6434_CR52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/sextrans-2017-053343","volume":"94","author":"N Thorley","year":"2018","unstructured":"Thorley N, Ross J. Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis? Sex Transm Infect. 2018;94(8):574\u20137.","journal-title":"Sex Transm Infect"},{"issue":"12","key":"6434_CR53","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/OLQ.0000000000000203","volume":"41","author":"A Brittingham","year":"2014","unstructured":"Brittingham A, Wilson WA. The antimicrobial effect of boric acid on Trichomonas vaginalis. Sex Transm Dis. 2014;41(12):718.","journal-title":"Sex Transm Dis"},{"issue":"10","key":"6434_CR54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/OLQ.0000000000001420","volume":"48","author":"S Surapaneni","year":"2021","unstructured":"Surapaneni S, Akins R, Sobel JD. Recurrent bacterial vaginosis: an unmet therapeutic challenge. Experience with a combination pharmacotherapy long-term suppressive regimen. Sex Transm Dis. 2021;48(10):761.","journal-title":"Sex Transm Dis"},{"issue":"2","key":"6434_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/jac\/dkn486","volume":"63","author":"F De Seta","year":"2009","unstructured":"De Seta F, Schmidt M, Vu B, Essmann M, Larsen B. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother. 2009;63(2):325\u201336.","journal-title":"J Antimicrob Chemother"},{"key":"6434_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01063-1","author":"R Khasriya","year":"2025","unstructured":"Khasriya R, Horsley H. Why women are not treated equally in healthcare and what can be done. Nat Rev Urol. 2025. https:\/\/doi.org\/10.1038\/s41585-025-01063-1.","journal-title":"Nat Rev Urol"},{"issue":"12","key":"6434_CR57","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s43587-023-00509-8","volume":"3","author":"G Gilmer","year":"2023","unstructured":"Gilmer G, Hettinger ZR, Tuakli-Wosornu Y, Skidmore E, Silver JK, Thurston RC, et al. Female aging: when translational models don\u2019t translate. Nat Aging. 2023;3(12):1500\u20138.","journal-title":"Nat Aging"},{"issue":"1","key":"6434_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00404-020-05821-x","volume":"303","author":"FD Tidbury","year":"2021","unstructured":"Tidbury FD, Langhart A, Weidlinger S, Stute P. Non-antibiotic treatment of bacterial vaginosis\u2014a systematic review. Arch Gynecol Obstet. 2021;303(1):37\u201345.","journal-title":"Arch Gynecol Obstet"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06434-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:03:14Z","timestamp":1784556194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06434-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6434"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06434-1","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Financial Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}